ArticleCancers2020

Metabolic Plasticity Is an Essential Requirement of Acquired Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia.

Miriam G Contreras Mostazo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.